Globus Medical Inc (GMED)

28.70
0.67 2.39
NYSE : Health Care
Prev Close 28.03
Open 27.93
Day Low/High 27.79 / 28.70
52 Wk Low/High 19.25 / 28.44
Volume 601.52K
Avg Volume 1.07M
Exchange NYSE
Shares Outstanding 95.83M
Market Cap 2.70B
EPS 1.20
Div & Yield N.A. (N.A)

Latest News

First Week of September 15th Options Trading For Globus Medical (GMED)

First Week of September 15th Options Trading For Globus Medical (GMED)

Investors in Globus Medical Inc saw new options begin trading this week, for the September 15th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 234 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Globus Medical Announces CE Mark For Excelsius GPS™

Globus Medical Announces CE Mark For Excelsius GPS™

Excelsius GPS™ - Robotic Trajectory Guidance and Navigation for Surgery

Globus Medical Stock Sees Short Interest Fall 13%

Globus Medical Stock Sees Short Interest Fall 13%

The most recent short interest data has been released for the 11/15/2016 settlement date, which shows a 990,027 share decrease in total short interest for Globus Medical Inc , to 6,671,333, a decrease of 12.92% since 10/31/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Analysts' Actions -- F5 Networks, GoPro, Lockheed Martin, U.S. Steel and More

Analysts' Actions -- F5 Networks, GoPro, Lockheed Martin, U.S. Steel and More

Here are Wednesday's top research calls, including upgrades for F5 Networks, U.S. Steel, Lockheed Martin and Sysco, and downgrades for GoPro, Kansas City Southern, Globus and Constellation Brands.

Globus Medical Launches INDEPENDENCE MIS™, A Minimally Invasive ALIF Integrated Plate-Spacer

Globus Medical Launches INDEPENDENCE MIS™, A Minimally Invasive ALIF Integrated Plate-Spacer

INDEPENDENCE MIS™ enhances the ALIF surgical technique by offering fewer procedural steps and a less invasive surgical corridor than traditional integrated spacers

Globus Medical Launches QUARTEX™ OCT Stabilization System

Globus Medical Launches QUARTEX™ OCT Stabilization System

QUARTEX™ Occipito-Cervico-Thoracic (OCT) Stabilization System is a threaded screw and rod platform offering true thoracic pedicle screws with diameters up to 5.5 mm, allowing surgeons to take full advantage of varying spinal anatomy.

November 18th Options Now Available For Globus Medical (GMED)

November 18th Options Now Available For Globus Medical (GMED)

Investors in Globus Medical Inc saw new options become available today, for the November 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GMED options chain for the new November 18th contracts and identified one put and one call contract of particular interest.

Trade-Ideas: Globus Medical (GMED) Is Today's

Trade-Ideas: Globus Medical (GMED) Is Today's "Dead Cat Bounce" Stock

Trade-Ideas LLC identified Globus Medical (GMED) as a "dead cat bounce" (down big yesterday but up big today) candidate

Analysts' Actions -- Alaska Air, Southwest, Coach, Twitter and More

Analysts' Actions -- Alaska Air, Southwest, Coach, Twitter and More

Here are Wednesday's top research calls, including upgrades for Coach and Alaska Air, and downgrades for Southwest Airlines and Twitter.

These 5 Stocks Are Breaking Out This Summer

These 5 Stocks Are Breaking Out This Summer

These five technical setups are showing solid upside potential right now.

2 Fundamentally Strong Medical Device Stocks to Buy Now

2 Fundamentally Strong Medical Device Stocks to Buy Now

The health care sector is booming, but many stocks are overvalued. We pinpoint the best buys now in the medical device niche.

4 Medical Device Makers With Healthy-Looking Charts

4 Medical Device Makers With Healthy-Looking Charts

These medical device makers could be acquisition targets (and one buyer) following Zimmer Biomet's takeout of LDR Holding. Their charts are also buys, says technical chartist Bruce Kamich.

Zimmer's LDR Deal Could Force Others to Grow a Dealmaking Spine

Zimmer's LDR Deal Could Force Others to Grow a Dealmaking Spine

The $1 billion transaction could inspire other medical device companies and private equity firms to bend over backwards for spinal device assets.

Noteworthy Wednesday Option Activity: GMED, IMMR, BKS

Noteworthy Wednesday Option Activity: GMED, IMMR, BKS

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Globus Medical Inc , where a total volume of 3,046 contracts has been traded thus far today, a contract volume which is representative of approximately 304,600 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 54.1% of GMED's average daily trading volume over the past month, of 563,450 shares.

Rival Offer for LDR Is Unlikely, but Never Say Never

Rival Offer for LDR Is Unlikely, but Never Say Never

The hefty premium Zimmer Biomet is paying in the $1 billion deal for the spine company suggests the target's management followed a competitive process.

Globus Medical (GMED) Stock Receives ‘Equal Weight’ Rating at Barclays

Globus Medical (GMED) Stock Receives ‘Equal Weight’ Rating at Barclays

Globus Medical (GMED) coverage was started with an ‘equal weight’ rating and $26 price target at Barclays.

Analysts' Actions -- J.C. Penney, Kohl's, Microsoft, Nokia and More

Analysts' Actions -- J.C. Penney, Kohl's, Microsoft, Nokia and More

Here are Monday's top research calls, including upgrades for J.C. Penney and Nokia, a downgrade for Kohl's and new coverage of Microsoft.

Globus Medical (GMED) Is Weak On High Volume Today

Globus Medical (GMED) Is Weak On High Volume Today

Trade-Ideas LLC identified Globus Medical (GMED) as a weak on high relative volume candidate